AV
Publications
- The immune cell atlas of human neuroblastoma
- A dynamic mutational landscape associated with an inter-regionally diverse immune response in malignant rhabdoid tumour
- Reply to Heng: Inborn aneuploidy and chromosomal instability
- BCOR internal tandem duplication and YWHAE-NUTM2B/E fusion are mutually exclusive events in clear cell sarcoma of the kidney.
- Somatic Genetic Variation in Children: from Mosaicism to Cancer
- DEVOLUTION—A method for phylogenetic reconstruction of aneuploid cancers based on multiregional genotyping data
- Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
- Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers
- Whole chromosome gain does not in itself confer cancer-like chromosomal instability.
- Reply to Duesberg: Stability of peritriploid and triploid states in neoplastic and nonneoplastic cells
- Elevated tolerance to aneuploidy in cancer cells: estimating the fitness effects of chromosome number alterations by in silico modelling of somatic genome evolution.
- Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.
- Confined trisomy 8 mosaicism of meiotic origin: A rare cause of aneuploidy in childhood cancer.
- Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
- Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
- Aberrant epigenetic regulation in clear cell sarcoma of the kidney featuring distinct DNA hypermethylation and EZH2 overexpression.
- The fetal thymus has a unique genomic copy number profile resulting from physiological T cell receptor gene rearrangement
- Neuroblastoma with flat genomic profile
- Extensive clonal branching shapes the evolutionary history of high-risk pediatric cancers
- Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST
- Re: Case reports and systematic review suggest that children may experience similar long‐term effects to adults after clinical COVID‐19
- Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?
- ZMIZ1-associated neurodevelopmental disorder and Hirschsprung disease
- Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST
- Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
- Resolving the pathogenesis of anaplastic Wilms tumors through spatial mapping of cancer cell evolution
- Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S4 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S4 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S2 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S2 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Table S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Figure S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Figure S1 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Fig S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Fig S3 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Fig S2 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Fig S2 from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Data from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- Data from Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
- A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage